Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-15-086146
Filing Date
2015-12-18
Accepted
2015-12-18 17:10:59
Documents
1
Period of Report
2015-12-16

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3637
  Complete submission text file 0001209191-15-086146.txt   4989
Mailing Address 20 FIRSTFIELD ROAD GAITHERSBURG MD 20878
Business Address 20 FIRSTFIELD ROAD GAITHERSBURG MD 20878 240-268-2000
NOVAVAX INC (Issuer) CIK: 0001000694 (see all company filings)

EIN.: 222816046 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O NOVAVAX, INC. 20 FIRSTFIELD ROAD GAITHERSBURG MD 20878
Business Address
Herrmann John A III (Reporting) CIK: 0001610928 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-26770 | Film No.: 151297535